However, role of 2-DG in regulating pyroptosis, especially in breast cancer, where metabolic traits (e.g., elevated glycolysis) (13) and subtype heterogeneity (e.g., higher hexokinase-2 (HK2) expression in triple-negative breast cancer) (13) may alter responses, remains unclear. Here, HK2 is linked to breast carcinoma.